These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
20-3672603
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
12300 Grant Street, Thornton, CO
|
|
80241
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
|
|
o
|
|
Accelerated filer
|
|
o
|
|
|
|
|
|
|||
|
Non-accelerated filer
|
|
o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
x
|
|
|
|
|
|
Emerging growth company
|
|
o
|
|
|
|
|
|
|
||
|
Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
||
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
|
|
March 31,
2017 |
|
December 31,
2016 |
||||
|
ASSETS
|
|
|
|
|
||||
|
Current Assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
47,977
|
|
|
$
|
130,946
|
|
|
Trade receivables, net of allowance for doubtful accounts of $246,116 and $60,347, respectively
|
|
15,299
|
|
|
549,204
|
|
||
|
Inventories
|
|
1,306,143
|
|
|
2,569,816
|
|
||
|
Prepaid expenses and other current assets
|
|
553,320
|
|
|
983,796
|
|
||
|
Total current assets
|
|
1,922,739
|
|
|
4,233,762
|
|
||
|
Property, Plant and Equipment
|
|
36,639,460
|
|
|
36,639,460
|
|
||
|
Less accumulated depreciation and amortization
|
|
(31,318,072
|
)
|
|
(30,983,448
|
)
|
||
|
|
|
5,321,388
|
|
|
5,656,012
|
|
||
|
Other Assets:
|
|
|
|
|
||||
|
Patents, net of accumulated amortization of $302,864 and $169,626, respectively
|
|
1,554,626
|
|
|
1,647,505
|
|
||
|
Other non-current assets
|
|
72,626
|
|
|
77,562
|
|
||
|
|
|
1,627,252
|
|
|
1,725,067
|
|
||
|
Total Assets
|
|
$
|
8,871,379
|
|
|
$
|
11,614,841
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
|
|
|
|
||||
|
Current Liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
2,297,000
|
|
|
$
|
4,902,471
|
|
|
Related party payables
|
|
223,086
|
|
|
214,903
|
|
||
|
Accrued expenses
|
|
1,874,737
|
|
|
1,469,684
|
|
||
|
Current portion of long-term debt
|
|
326,855
|
|
|
243,113
|
|
||
|
Notes Payable
|
|
1,172,026
|
|
|
—
|
|
||
|
Promissory Notes, net of discount of $15,000 and $0, respectively
|
|
3,785,000
|
|
|
1,430,000
|
|
||
|
Current portion of litigation settlement
|
|
196,215
|
|
|
339,481
|
|
||
|
Series E preferred stock, net of discount of $55,685 and $63,640, respectively
|
|
49,315
|
|
|
56,360
|
|
||
|
Series F preferred stock
|
|
160,001
|
|
|
160,001
|
|
||
|
Series G preferred stock, net of discount of $464,766 and $699,674, respectively
|
|
271,234
|
|
|
408,326
|
|
||
|
July 2016 convertible notes, net of discount of $817,203 and $1,634,357, respectively
|
|
961,632
|
|
|
1,159,610
|
|
||
|
Series I exchange notes, net of discount of $130,840 and $199,474, respectively
|
|
25,231
|
|
|
26,597
|
|
||
|
Series J preferred stock, net of discount of $440,640 and $0, respectively
|
|
684,360
|
|
|
1,350,000
|
|
||
|
Series K preferred stock
|
|
150,000
|
|
|
—
|
|
||
|
October 2016 convertible notes, net of discount of $198,000 and $264,000 respectively
|
|
132,000
|
|
|
66,000
|
|
||
|
Tertius Financial Group promissory notes, net of discount of $0 and $59,658, respectively
|
|
—
|
|
|
542,808
|
|
||
|
Short term embedded derivative liabilities
|
|
4,027,659
|
|
|
6,578,154
|
|
||
|
Make-whole dividend liability
|
|
246,649
|
|
|
500,176
|
|
||
|
Total current liabilities
|
|
16,583,000
|
|
|
19,447,684
|
|
||
|
Long-Term Debt
|
|
5,378,077
|
|
|
5,281,776
|
|
||
|
Accrued Warranty Liability
|
|
168,968
|
|
|
176,457
|
|
||
|
Commitments and Contingencies (Notes 4 & 23)
|
|
|
|
|
||||
|
Mezzanine Equity:
|
|
|
|
|
||||
|
Series J-1 preferred stock: 700 shares authorized; 700 and issued and outstanding as of March 31, 2017 and December 31, 2016
|
|
700,000
|
|
|
700,000
|
|
||
|
Stockholders’ Deficit:
|
|
|
|
|
||||
|
Series A preferred stock, $.0001 par value; 750,000 shares authorized and issued; 60,756 shares and 125,044 shares outstanding as of March 31, 2017 and December 31, 2016, respectively ($729,072 and $1,500,528 Liquidation Preference)
|
|
6
|
|
|
13
|
|
||
|
Common stock, $0.0001 par value, 20,000,000,000 shares authorized; 2,561,968,275 and 554,223,320 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively
|
|
256,197
|
|
|
55,422
|
|
||
|
Additional paid in capital
|
|
375,296,240
|
|
|
369,886,065
|
|
||
|
Accumulated deficit
|
|
(389,511,109
|
)
|
|
(383,932,576
|
)
|
||
|
Total stockholders’ deficit
|
|
(13,958,666
|
)
|
|
(13,991,076
|
)
|
||
|
Total Liabilities, Mezzanine Equity and Stockholders’ Deficit
|
|
$
|
8,871,379
|
|
|
$
|
11,614,841
|
|
|
|
|
For the Three Months Ended
|
|
||||||
|
|
|
March 31,
|
|
||||||
|
|
|
2017
|
|
2016
|
|
||||
|
|
|
|
|
|
|
||||
|
Revenues
|
|
$
|
280,603
|
|
|
$
|
710,222
|
|
|
|
Costs and Expenses:
|
|
|
|
|
|
||||
|
Cost of revenues (exclusive of depreciation shown below)
|
|
1,492,841
|
|
|
2,164,396
|
|
|
||
|
Research, development and manufacturing operations (exclusive of depreciation shown below)
|
|
1,276,865
|
|
|
1,686,417
|
|
|
||
|
Inventory impairment costs
|
|
363,758
|
|
|
—
|
|
|
||
|
Selling, general and administrative (exclusive of depreciation shown below)
|
|
1,764,230
|
|
|
2,986,847
|
|
|
||
|
Depreciation and amortization
|
|
371,653
|
|
|
1,376,201
|
|
|
||
|
Total Costs and Expenses
|
|
5,269,347
|
|
|
8,213,861
|
|
|
||
|
Loss from Operations
|
|
(4,988,744
|
)
|
|
(7,503,639
|
)
|
|
||
|
Other Income/(Expense)
|
|
|
|
|
|
||||
|
Other Income, net
|
|
728,485
|
|
|
—
|
|
|
||
|
Interest expense
|
|
(1,991,352
|
)
|
|
(2,248,139
|
)
|
|
||
|
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net
|
|
673,078
|
|
|
(773,236
|
)
|
|
||
|
Total Other Expense
|
|
(589,789
|
)
|
|
(3,021,375
|
)
|
|
||
|
Net Loss
|
|
$
|
(5,578,533
|
)
|
|
$
|
(10,525,014
|
)
|
|
|
|
|
|
|
|
|
||||
|
Net Loss Per Share (Basic and diluted)
|
|
$
|
(0.0033
|
)
|
|
$
|
(0.0542
|
)
|
|
|
Weighted Average Common Shares Outstanding (Basic and diluted)
|
|
1,665,310,868
|
|
|
194,214,863
|
|
|
||
|
|
|
|
|
||||||
|
|
|
Three Months Ended
|
|
||||||
|
|
|
March 31,
|
|
||||||
|
|
|
2017
|
|
2016
|
|
||||
|
Operating Activities:
|
|
|
|
|
|
||||
|
Net loss
|
|
$
|
(5,578,533
|
)
|
|
$
|
(10,525,014
|
)
|
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
||||||
|
Depreciation and amortization
|
|
371,653
|
|
|
1,376,201
|
|
|
||
|
Share based compensation
|
|
79,737
|
|
|
217,838
|
|
|
||
|
Realized loss (gain) on sale of assets
|
|
(1,205,663
|
)
|
|
—
|
|
|
||
|
Amortization of financing costs to interest expense
|
|
35,164
|
|
|
80,089
|
|
|
||
|
Write down of previously capitalized inventory
|
|
363,758
|
|
|
—
|
|
|
||
|
Non-cash interest expense
|
|
575,015
|
|
|
54,379
|
|
|
||
|
Amortization of debt discount
|
|
1,474,135
|
|
|
1,923,705
|
|
|
||
|
Change in fair value of derivatives and gain/loss on extinguishment of liabilities, net
|
|
(673,078
|
)
|
|
773,236
|
|
|
||
|
Inducement conversion costs
|
|
407,974
|
|
|
—
|
|
|
||
|
Bad debt expense
|
|
4,082
|
|
|
16,993
|
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||||
|
Accounts receivable
|
|
533,822
|
|
|
453,454
|
|
|
||
|
Inventories
|
|
899,915
|
|
|
119,889
|
|
|
||
|
Prepaid expenses and other current assets
|
|
394,550
|
|
|
(318,848
|
)
|
|
||
|
Accounts payable
|
|
(249,691
|
)
|
|
(183,326
|
)
|
|
||
|
Accrued expenses
|
|
56,721
|
|
|
298,153
|
|
|
||
|
Accrued litigation settlement
|
|
(143,266
|
)
|
|
(130,687
|
)
|
|
||
|
Warranty reserve
|
|
(7,489
|
)
|
|
(18,351
|
)
|
|
||
|
Net cash used in operating activities
|
|
(2,661,194
|
)
|
|
(5,862,289
|
)
|
|
||
|
Investing Activities:
|
|
|
|
|
|
||||
|
Proceeds from the sale of assets
|
|
150,000
|
|
|
—
|
|
|
||
|
Patent activity costs
|
|
(19,275
|
)
|
|
(66,470
|
)
|
|
||
|
Net cash provided by/(used in) investing activities
|
|
130,725
|
|
|
(66,470
|
)
|
|
||
|
Financing Activities:
|
|
|
|
|
|
||||
|
Payment of debt financing costs
|
|
(42,500
|
)
|
|
(25,000
|
)
|
|
||
|
Repayment of debt
|
|
—
|
|
|
(78,282
|
)
|
|
||
|
Proceeds from promissory note
|
|
2,340,000
|
|
|
—
|
|
|
||
|
Proceeds from Committed Equity Line
|
|
—
|
|
|
1,056,147
|
|
|
||
|
Proceeds from issuance of stock and warrants
|
|
150,000
|
|
|
5,000,000
|
|
|
||
|
Net cash provided by financing activities
|
|
2,447,500
|
|
|
5,952,865
|
|
|
||
|
Net change in cash and cash equivalents
|
|
(82,969
|
)
|
|
24,106
|
|
|
||
|
Cash and cash equivalents at beginning of period
|
|
130,946
|
|
|
326,217
|
|
|
||
|
Cash and cash equivalents at end of period
|
|
$
|
47,977
|
|
|
$
|
350,323
|
|
|
|
Supplemental Cash Flow Information:
|
|
|
|
|
|
||||
|
Cash paid for interest
|
|
$
|
20,415
|
|
|
$
|
139,090
|
|
|
|
Non-Cash Transactions:
|
|
|
|
|
|
||||
|
Non-cash conversions of preferred stock and convertible notes to equity
|
|
$
|
1,699,731
|
|
|
$
|
3,441,115
|
|
|
|
Make-whole provision on convertible preferred stock
|
|
$
|
257,152
|
|
|
$
|
—
|
|
|
|
Accounts payable converted to notes payable
|
|
$
|
1,172,026
|
|
|
$
|
—
|
|
|
|
|
|
As of March 31,
|
|
As of December 31,
|
||||
|
|
|
2017
|
|
2016
|
||||
|
Building
|
|
$
|
5,828,960
|
|
|
$
|
5,828,960
|
|
|
Furniture, fixtures, computer hardware and computer software
|
|
489,421
|
|
|
489,421
|
|
||
|
Manufacturing machinery and equipment
|
|
30,300,391
|
|
|
30,300,391
|
|
||
|
Net depreciable property, plant and equipment
|
|
36,618,772
|
|
|
36,618,772
|
|
||
|
Manufacturing machinery and equipment in progress
|
|
20,688
|
|
|
20,688
|
|
||
|
Property, plant and equipment
|
|
36,639,460
|
|
|
36,639,460
|
|
||
|
Less: Accumulated depreciation and amortization
|
|
(31,318,072
|
)
|
|
(30,983,448
|
)
|
||
|
Net property, plant and equipment
|
|
$
|
5,321,388
|
|
|
$
|
5,656,012
|
|
|
|
|
As of March 31,
|
|
As of December 31,
|
||||
|
|
|
2017
|
|
2016
|
||||
|
Raw materials
|
|
$
|
816,166
|
|
|
$
|
832,806
|
|
|
Work in process
|
|
—
|
|
|
635,130
|
|
||
|
Finished goods
|
|
489,977
|
|
|
1,101,880
|
|
||
|
Total
|
|
$
|
1,306,143
|
|
|
$
|
2,569,816
|
|
|
|
|
||
|
2017
|
$
|
243,113
|
|
|
2018
|
343,395
|
|
|
|
2019
|
366,757
|
|
|
|
2020
|
391,709
|
|
|
|
2021
|
418,358
|
|
|
|
Thereafter
|
3,941,600
|
|
|
|
|
$
|
5,704,932
|
|
|
Conversion Period
|
Preferred Series E Shares Converted
|
Value of Series E Preferred Shares (inclusive of accrued dividends)
|
Common Shares Issued
|
|||
|
Q4 2015
|
478
|
|
$
|
481,500
|
|
250,000
|
|
Q1 2016
|
1,220
|
|
1,239,436
|
|
1,132,000
|
|
|
Q2 2016
|
365
|
|
381,414
|
|
7,979,568
|
|
|
Q3 2016
|
523
|
|
548,896
|
|
21,973,747
|
|
|
Q4 2016
|
94
|
|
101,018
|
|
13,089,675
|
|
|
Q1 2017
|
15
|
|
16,248
|
|
8,289,964
|
|
|
|
2,695
|
|
$
|
2,768,512
|
|
52,714,954
|
|
Conversion Period
|
Preferred Series F Shares Converted
|
Value of Series F Preferred Shares (inclusive of accrued dividends)
|
Common Shares Issued
|
|||
|
Q1 2016
|
2,168
|
|
$
|
2,188,298
|
|
2,183,992
|
|
Q2 2016
|
3,234
|
|
3,300,931
|
|
6,649,741
|
|
|
Q3 2016
|
1,262
|
|
1,315,743
|
|
81,917,364
|
|
|
Q4 2016
|
176
|
|
185,118
|
|
27,276,005
|
|
|
|
6,840
|
|
$
|
6,990,090
|
|
118,027,102
|
|
Conversion Period
|
Preferred Series G Shares Converted
|
Value of Series G Preferred Shares (inclusive of accrued dividends)
|
Common Shares Issued
|
|||
|
Q4 2016
|
892
|
|
929,895
|
|
245,726,283
|
|
|
Q1 2017
|
372
|
|
397,970
|
|
327,718,386
|
|
|
|
1,264
|
|
$
|
1,327,865
|
|
573,444,669
|
|
Conversion Period
|
July 2016 Convertible Notes Converted
|
Common Shares Issued
|
||
|
Q4 2016
|
$
|
152,460
|
|
64,000,000
|
|
Q1 2017
|
1,017,732
|
|
959,704,543
|
|
|
|
$
|
1,170,192
|
|
1,023,704,543
|
|
Conversion Period
|
Exchange Convertible Notes Converted
|
Common Shares Issued
|
||
|
Q3 2016
|
$
|
15,000
|
|
1,470,588
|
|
Q4 2016
|
91,563
|
|
13,346,274
|
|
|
Q1 2017
|
70,000
|
|
50,503,662
|
|
|
|
$
|
176,563
|
|
65,320,524
|
|
Preferred Stock Series Designation
|
Shares Authorized
|
Shares Outstanding
|
||
|
Series A
|
750,000
|
|
60,756
|
|
|
Series B-1
|
2,000
|
|
—
|
|
|
Series B-2
|
1,000
|
|
—
|
|
|
Series C
|
690
|
|
—
|
|
|
Series D
|
3,000
|
|
—
|
|
|
Series D-1
|
2,500
|
|
—
|
|
|
Series E
|
2,800
|
|
105
|
|
|
Series F
|
7,000
|
|
160
|
|
|
Series G
|
2,000
|
|
736
|
|
|
Series H
|
2,500
|
|
—
|
|
|
Series I
|
1,000
|
|
—
|
|
|
Series J
|
1,350
|
|
1,125
|
|
|
Series J-1
|
700
|
|
700
|
|
|
Series K
|
20,000
|
|
150
|
|
|
|
|
For the three months ended March 31,
|
|
||||||
|
|
|
2017
|
|
2016
|
|
||||
|
Share-based compensation cost included in:
|
|
|
|
|
|
||||
|
Research and development
|
|
$
|
16,611
|
|
|
$
|
45,689
|
|
|
|
Selling, general and administrative
|
|
63,126
|
|
|
172,149
|
|
|
||
|
Total share-based compensation cost
|
|
$
|
79,737
|
|
|
$
|
217,838
|
|
|
|
|
|
For the three months ended March 31,
|
|
||||||
|
|
|
2017
|
|
2016
|
|
||||
|
Type of Award:
|
|
|
|
|
|
||||
|
Stock Options
|
|
$
|
53,408
|
|
|
$
|
95,384
|
|
|
|
Restricted Stock Units and Awards
|
|
26,329
|
|
|
122,454
|
|
|
||
|
Total share-based compensation cost
|
|
$
|
79,737
|
|
|
$
|
217,838
|
|
|
|
|
|
For the three months ended March 31,
|
||
|
|
|
2017
|
|
2016
|
|
Expected volatility
|
|
114%
|
|
114%
|
|
Risk free interest rate
|
|
1%
|
|
1%
|
|
Expected dividends
|
|
—
|
|
—
|
|
Expected life (in years)
|
|
6.0
|
|
5.8
|
|
•
|
The Company agreed to redeem for cash all secured convertible notes of the Company held by the holder no later than September 1, 2017.
|
|
•
|
The Company affirmed that the current balance of owed principal and accrued and unpaid interest to the holder is
$1,790,213.91
as of May 2, 2017.
|
|
•
|
The redemption price for such secured convertible notes shall be
120%
(if redeemed on or prior to August 15, 2017)or
125%
(if redeemed after August 15, 2017) of the then outstanding principal, plus any accrued and unpaid interest.
|
|
•
|
During the month of May 2017, the Holder agreed to limit its conversions of outstanding Company secured convertible notes to
$50,000
per calendar week of principal/interest.
|
|
•
|
During the months of June, July and August 2017, the holder agreed to limit its conversions of outstanding Company secured convertible notes to
$75,000
per calendar week of principal/interest.
|
|
•
|
During the months of May, June, July and August 2017, the holder agreed that all outstanding Company secured convertible notes shall bear interest at the normal stated, rather than default, interest rate.
|
|
•
|
All conversions during the months of May, June, July and August 2017 will be at the “triggering event” discount conversion price as stated in the secured convertible notes, and will continue at the “triggering event” discount price until, if and when the notes are redeemed.
|
|
•
|
Should the Company fail to redeem for cash all secured convertible notes on or before September 1, 2017, default interest and normal stated interest will accrue from the date of execution of this agreement.
|
|
•
|
our ability to generate customer acceptance of and demand for our products;
|
|
•
|
successful ramping up of commercial production on the equipment installed;
|
|
•
|
our products are successfully and timely certified for use in our target markets;
|
|
•
|
successful operating of production tools to achieve the efficiencies, throughput and yield necessary to reach our cost targets;
|
|
•
|
the products we design are saleable at a price sufficient to generate profits;
|
|
•
|
our ability to raise sufficient capital to enable us to reach a level of sales sufficient to achieve profitability on terms favorable to us;
|
|
•
|
effective management of the planned ramp up of our domestic and international operations;
|
|
•
|
our ability to successfully develop and maintain strategic relationships with key partners, including OEMs, system integrators, distributors, retailers and e-commerce companies, who deal directly with end users in our target markets;
|
|
•
|
our ability to maintain the listing of our common stock on the OTCQB Venture Market;
|
|
•
|
our ability to implement remediation measures to address material weaknesses in control;
|
|
•
|
our ability to achieve projected operational performance and cost metrics;
|
|
•
|
our ability to enter into commercially viable licensing, joint venture, or other commercial arrangements; and
|
|
•
|
availability of raw materials.
|
|
1.
|
Personnel related expenses decreased
$352,000
as compared to the
first
quarter of 2016. The decrease in personnel related costs was primarily due to a reduction in headcount.
|
|
2.
|
Consulting and contract services decreased by
$19,000
compared to the first quarter of 2016. The decrease in expense as compared to the
first
quarter of 2016 was primarily attributed to the reduced number of contractors during the quarter ended
March 31, 2017
.
|
|
3.
|
Materials and equipment related expenses decreased
$34,000
compared to the first quarter of 2016. The decrease in expense was primarily due to the reserve against WIP inventory as a result of our focus transition from the consumer electronics market to high-value PV markets.
|
|
1.
|
Personnel related costs decreased
$481,000
during the three months ended
March 31, 2017
as compared to the three months ended
March 31, 2016
. The overall decrease in personnel related costs was primarily due a lower headcount for the three months ended
March 31, 2017
as compared to the three months ended
March 31, 2016
.
|
|
2.
|
Marketing and related expenses decreased
$682,000
during the three months ended
March 31, 2017
as compared to the three months ended
March 31, 2016
. The decrease in Marketing and related expenses is due to reduced marketing, advertising, and promotional activities during the third quarter of 2016 as compared to the first quarter of 2016 which the direct result of moving from the consumer electronics market to higher-value PV markets.
|
|
3.
|
Consulting and contract services increased
$128,000
during the three months ended
March 31, 2017
as compared to the three months ended
March 31, 2016
. The increase was a result of increased consulting expenses related to our financing efforts.
|
|
4.
|
Legal expenses decreased
$170,000
during the three months ended
March 31, 2017
as compared to the three months ended
March 31, 2016
. The primary reasons for the decrease is due to reductions in both legal expenses related to our patents and general legal expenses related to financing efforts as compared to the quarter ended
March 31, 2016
.
|
|
5.
|
Bad debt expense decreased
$11,000
during the three months ended
March 31, 2017
as compared to the three months ended
March 31, 2016
. During the quarter we recorded payments and settlements against existing reserves which were offset by additional reserves for customers whose accounts were greater than 120 days overdue.
|
|
1.
|
Interest expense decreased
$257,000
as compared the first quarter of 2016. The decrease is primarily due to a reduction in non-cash interest expense and amortization of debt discount related to certain convertible notes and Series' E, F, H, and I Preferred Stock, offset by non-cash interest expense and amortization of debt discounts related to certain convertible and promissory notes and Series G, J, and J-1 Preferred Stock.
|
|
2.
|
Other income, net increased
$728,000
. This increase is comprised of a
$1,209,000
increase in gain on sale of assets after the transfer of the EnerPlex IP, offset by induced conversion costs of $480,000 on several of the financial instruments.
|
|
2.
|
Gains and losses on change in fair value of derivatives and on extinguishment of liabilities, net increased
$1,446,000
as compared to the first quarter of 2016. The increase in this non-cash item is the result of an increase of
$2,621,268
in the gain on change in the fair value of our embedded derivative instruments during the three months ended
March 31, 2017
compared to the three months ended
March 31, 2016
, offset by an increase of
$1,174,954
on loss on extinguishments of liabilities related to conversions of certain convertible notes and preferred stock in the same comparative periods.
|
|
|
|
Decrease (Increase)
to Net Loss
For the Three
Months Ended
March 31, 2017 Compared to the Three Months Ended
March 31, 2016
|
||
|
Revenues
|
|
(430,000
|
)
|
|
|
Cost of Revenue
|
|
672,000
|
|
|
|
Research, development and manufacturing operations
|
|
|
||
|
Materials and Equipment Related Expenses
|
|
34,000
|
|
|
|
Personnel Related Expenses
|
|
352,000
|
|
|
|
Consulting and Contract Services
|
|
19,000
|
|
|
|
Facility Related Expenses
|
|
(4,000
|
)
|
|
|
Other Miscellaneous Costs
|
|
8,000
|
|
|
|
Selling, general and administrative expenses
|
|
|
||
|
Personnel Related Expenses
|
|
481,000
|
|
|
|
Marketing Related Expenses
|
|
682,000
|
|
|
|
Legal Expenses
|
|
170,000
|
|
|
|
Public Company Costs
|
|
7,000
|
|
|
|
Consulting and Contract Services
|
|
(128,000
|
)
|
|
|
Other Miscellaneous Costs
|
|
11,000
|
|
|
|
Depreciation and Amortization Expense
|
|
1,005,000
|
|
|
|
Other Income / (Expense)
|
|
|
||
|
Interest Expense
|
|
257,000
|
|
|
|
Other Income/Expense
|
|
728,000
|
|
|
|
Non-Cash Change in Fair Value of Derivatives and Gain/Loss on Extinguishment of Liabilities, net
|
|
1,446,000
|
|
|
|
Decrease (Increase) to Net Loss
|
|
$
|
5,310,000
|
|
|
|
|
|
|
Payments Due by Year (in thousands)
|
||||||||||||||||
|
Contractual Obligations
|
|
Total
|
|
Less Than 1
Year
|
|
1-3 Years
|
|
3-5 Years
|
|
More Than 5
Years
|
||||||||||
|
Long-term debt obligations
|
|
$
|
8,222
|
|
|
$
|
694
|
|
|
$
|
2,081
|
|
|
$
|
1,387
|
|
|
$
|
4,060
|
|
|
Litigation Settlement
|
|
200
|
|
|
200
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Purchase obligations
|
|
684
|
|
|
684
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total
|
|
$
|
9,106
|
|
|
$
|
1,578
|
|
|
$
|
2,081
|
|
|
$
|
1,387
|
|
|
$
|
4,060
|
|
|
•
|
The Company was understaffed and did not have sufficiently trained resources with the technical expertise to research and account for the Company's complex capitalization and multiple complex capital raising and equity transactions. This deficiency arose primarily from staff turnover including the Company’s failure to more quickly replace its Director of Financial Planning and Reporting, who left the Company for a new position in November, 2016.
|
|
•
|
Accounting for the Company's convertible debt and preferred stock transactions was lacking for the preparation of the December 31, 2016 financial statements. Many of the special accounting issues specific to debt and equity financing have become increasingly complex and time-consuming, and require extensive expertise to ensure that the accounting and reporting are accurate and in accordance with applicable standards. Given the numerous complex convertible equity financing transactions engaged in by the Company during 2016, the relevant accounting standards require the calculation, monitoring, recalculation and “marking to market” of a wide variety of derivative securities instruments that are deemed to arise from such financing transactions. These complex derivatives calculations are used in order to calculate the intrinsic value of the financial instruments and affect the short term embedded derivative liabilities line item on the Company’s balance sheet and in the change in fair value of derivatives and gain/loss on extinguishment of liabilities line item on the Company’s consolidated statement of operations. As the calculations in question relate to non-cash transactions, there was no impact on the Company's cash, current assets, revenues, operating results, or cash flows. The control deficiencies described above created a reasonable possibility that a material misstatement to the consolidated financial statements would not be prevented or detected on a timely basis.
|
|
•
|
In March 2017, the Company hired a Director of Financial Planning and Reporting with the technical expertise to research and account for the Company's complex capital raising and financial transactions. In addition, the Company will be evaluating its personnel needs and other resources to ensure appropriate staffing and enhance its research and technical accounting knowledge base.
|
|
•
|
The Company will design and implement additional procedures in order to assure that the Director, Financial Planning and Reporting and other audit/accounting personnel are more involved with the Company’s financing activities to monitor and earlier identify accounting issues that may be raised by the Company’s ongoing financing activities.
|
|
|
ASCENT SOLAR TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
By:
|
/
S
/ VICTOR LEE
|
|
|
|
Lee Kong Hian (aka Victor Lee)
President and Chief Executive Officer
(Principal Executive Officer, Principal Financial Officer, Chief Accounting Officer, and Authorized Signatory)
|
|
3.1
|
|
Certificate of Designations of Preferences, Rights and Limitations of Series K Preferred Stock (incorporated by reference to Exhibit 2 to Exhibit 10.1 to our Current Report on Form 8-K filed February 14, 2017)
|
|
3.2
|
|
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company dated March 16, 2017 (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed March 17, 2017)
|
|
10.1
|
|
Note dated January 10, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed January 17, 2017)
|
|
10.2
|
|
Note dated January 16, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 20, 2017)
|
|
10.3
|
|
Note dated January 17, 2017 (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on January 20, 2017)
|
|
10.4
|
|
Securities Purchase Agreement dated January 19, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed January 24, 2017)
|
|
10.5
|
|
Note dated February 7, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed February 9, 2017)
|
|
10.6
|
|
Series K Securities Purchase Agreement dated February 8, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed February 14, 2017)
|
|
10.7
|
|
Note dated February 13, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed February 17, 2017)
|
|
10.8
|
|
Note dated February 27, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed March 1, 2017)
|
|
10.9
|
|
Intellectual Property Disposal Agreement dated as of January 25, 2017 and effective February 23, 2017 (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed March 1, 2017)
|
|
10.10
|
|
Note dated March 13, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed March 17, 2017)
|
|
10.11
|
|
Note dated March 24, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed March 29, 2017)
|
|
10.12
|
|
Note dated April 6, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed April 7, 2017)
|
|
10.13
|
|
Note dated April 21, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed April 24, 2017)
|
|
10.14
|
|
Forbearance and Settlement Agreement dated May 5, 2017 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed May 10, 2017)
|
|
10.15
|
|
Note dated May 8, 2017 (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed May 10, 2017)
|
|
31.1*
|
|
Chief Executive Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002
|
|
31.2*
|
|
Chief Financial Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002
|
|
32.1*
|
|
Chief Executive Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002
|
|
32.2*
|
|
Chief Financial Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
*
|
Filed herewith.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|